ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,487,573 | -13.4% | 2,291,177 | +6.6% | 0.00% | -20.0% |
| Q2 2023 | $14,426,862 | -0.9% | 2,149,946 | +30.4% | 0.01% | 0.0% |
| Q1 2023 | $14,554,198 | +186731.8% | 1,648,361 | +61.6% | 0.01% | +150.0% |
| Q4 2022 | $7,790 | -99.8% | 1,019,739 | +49.7% | 0.00% | 0.0% |
| Q3 2022 | $4,848,000 | +44.2% | 681,077 | +63.9% | 0.00% | +100.0% |
| Q2 2022 | $3,361,000 | -47.7% | 415,484 | -10.2% | 0.00% | -50.0% |
| Q1 2022 | $6,425,000 | -51.7% | 462,924 | -2.4% | 0.00% | -50.0% |
| Q4 2021 | $13,315,000 | +86.9% | 474,508 | +126.4% | 0.00% | +100.0% |
| Q3 2021 | $7,124,000 | +38.3% | 209,606 | +66.3% | 0.00% | 0.0% |
| Q2 2021 | $5,151,000 | -4.9% | 126,057 | -6.3% | 0.00% | 0.0% |
| Q1 2021 | $5,414,000 | +9.3% | 134,492 | +60.5% | 0.00% | 0.0% |
| Q4 2020 | $4,955,000 | +644.0% | 83,791 | +511.6% | 0.00% | – |
| Q3 2020 | $666,000 | -54.4% | 13,700 | -54.6% | 0.00% | -100.0% |
| Q2 2020 | $1,461,000 | +55.9% | 30,206 | -10.4% | 0.00% | – |
| Q1 2020 | $937,000 | – | 33,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |